ויפנד 40 מ"ג/מ"ל אבקה להכנת תרחיף למתן דרך הפה - Vfend 40 mg/ml powder for oral suspension
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× |
| ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | J02AC Triazole derivatives | ||||||||||||||||||||||||||||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||||||||||||||
| צ×רת ××ª× | פ××× - PER OS | ||||||||||||||||||||||||||||||
| צ×רת ××× ×× | ×××§× ×××× ×ª תר×××£, POWDER FOR SUSPENSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||||||||||||||
| ×ת×××× | Treatment of : - invasive aspergillosis, - fluconazole-resistant serious invasive Candida infections (including C. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.- Vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. - Treatment of candidemia in non neutropenic patients.- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.
| ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 Â
| ||||||||||||||||||||||||||||||
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×××¤× × 40 ×"×/×"× ×××§× ×××× ×ª תר×××£ ×××ª× ××¨× ××¤× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | FAREVA AMBOISE, FRANCE |
| ×©× ××¢× ×ר×ש×× | PFIZER PFE PHARMACEUTICALS ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 11/2004. ר×ש××× ×ת×ר××: 06/2011 |
| ת×ר×× ×¢×××× ××ר×× | 15/05/19 |
ת××× ×ª ×ר×××
השינוי האחרון נעשה בֹ־3 בדצמבר 2021 ב־12:36